Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Cancer Cell
|
November 11, 2022
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
Stefan Salcher, Gregor Sturm, Lena Horvath, et al.
Blood Advances
|
May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia
Jan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Translational Lung Cancer Research
|
May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysis
Tian Tian, Yanying Li, Juan Li, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Molecular Cancer
|
October 22, 2025
Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusion
Manuel Trebo, Thomas Maurer, Felix J Krendl, et al.
Molecular Cancer
|
June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Cell Metabolism
|
July 19, 2018
Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells
Saar Vandekeere, Charlotte Dubois, Joanna Kalucka, et al.
Intensive Care Medicine
|
June 30, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosis
Michael Ruzicka, Hans Christian Stubbe, Josia Fauser, et al.
Blood
|
March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
Sascha Dietrich, Andreas Pircher, Volker Endris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Cancer Cell
|
November 11, 2022
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
Stefan Salcher, Gregor Sturm, Lena Horvath, et al.
Blood Advances
|
May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia
Jan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Translational Lung Cancer Research
|
May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysis
Tian Tian, Yanying Li, Juan Li, et al.
Therapeutic Advances in Medical Oncology
|
March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
Isabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
Molecular Cancer
|
October 22, 2025
Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusion
Manuel Trebo, Thomas Maurer, Felix J Krendl, et al.
Molecular Cancer
|
June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Cell Metabolism
|
July 19, 2018
Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells
Saar Vandekeere, Charlotte Dubois, Joanna Kalucka, et al.
Intensive Care Medicine
|
June 30, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosis
Michael Ruzicka, Hans Christian Stubbe, Josia Fauser, et al.
Blood
|
March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
Sascha Dietrich, Andreas Pircher, Volker Endris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Page
of 10